ERAS: Improving outcome in the cachectic HPB patient

Area of Science:

• Hepatopancreatobiliary (HPB) surgery
• Surgical oncology
• Enhanced recovery after surgery (ERAS) protocols

Background:

• Enhanced recovery after surgery (ERAS) programs have improved surgical outcomes, reducing morbidity and hospital stay for hepatopancreatobiliary (HPB) surgery patients.
• However, ERAS programs have not demonstrated a significant impact on mortality rates in this patient population.
• Cancer cachexia, characterized by severe weight and muscle loss, is prevalent in HPB surgery patients and may negatively influence surgical outcomes, even under ERAS protocols.

Purpose of the Study:

• To evaluate the effectiveness of ERAS programs in HPB surgery.
• To investigate the impact of cancer cachexia on HPB surgery outcomes within ERAS protocols.
• To determine the necessity of tailored ERAS approaches for HPB patients with cancer cachexia.

Main Methods:

• Review of existing literature on ERAS programs in HPB surgery.
• Analysis of patient data focusing on outcomes, morbidity, mortality, and hospital stay.
• Comparative analysis of outcomes between patients with and without cancer cachexia undergoing HPB surgery within ERAS protocols.

Main Results:

• ERAS programs significantly reduced postoperative morbidity and hospital stay duration in HPB surgery patients.
• ERAS programs did not show a significant reduction in mortality rates for HPB surgery patients.
• Cancer cachexia was identified as a potential factor negatively affecting outcomes in HPB surgery patients, even within ERAS programs.

Conclusions:

• ERAS programs are beneficial in reducing complications and length of stay for HPB surgery.
• Mortality remains a challenge in HPB surgery, irrespective of ERAS implementation.
• A tailored ERAS approach is recommended to optimize outcomes for vulnerable HPB surgery patients suffering from cancer cachexia.